Replies to post #79 on Dermata Therapeutics Inc (DRMA)

[The Night Stalker]

offering for 5m was done in march to fund operations till 2024

im all about funding operations, topline clinical trials, market caps and Deadline for phase 3 in june

interesting volume on monthly chart


https://www.stockscores.com/charts/charts/?ticker=drma

[The Night Stalker]

same sector as KALA btw had a homerun pop

Currently, Dermata has a Zacks Rank #3 (Hold).

Some better-ranked stocks for investors interested in the same sector are CRISPR Therapeutics CRSP, Kala Pharmaceuticals KALA and Allogene Therapeutics ALLO, each carrying a Zacks Rank #2 (Buy) at present